Penumbra, Inc Excess Tax Benefit from Share-based Compensation, Operating Activities
Penumbra, Inc (PEN) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $7.60 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2016-11-03
- Penumbra, Inc excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-09-30 was $3.23M, a 156.80% increase year-over-year.
- Penumbra, Inc excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-06-30 was $2.86M.
- Penumbra, Inc excess tax benefit from share-based compensation, operating activities for the quarter ending 2016-03-31 was $1.51M.
- Penumbra, Inc excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-12-31 was $333.00K.
- Penumbra, Inc excess tax benefit from share-based compensation, operating activities for fiscal 2015 was $1.59M.
- Penumbra, Inc excess tax benefit from share-based compensation, operating activities for fiscal 2014 was $0.00.
- Penumbra, Inc excess tax benefit from share-based compensation, operating activities for fiscal 2013 was $0.00.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|---|---|---|
| 2016-09-30 | $3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $6.09M derived: sum of 2 quarters · filed 2016-11-03 | $7.60M 10-Q · filed 2016-11-03 | $7.93M derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.37M 10-Q · filed 2016-08-09 | $4.71M derived: sum of 3 quarters · filed 2016-08-09 | $5.96M derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-03-31 | $1.51M 10-Q · filed 2016-05-09 | $1.84M derived: sum of 2 quarters · filed 2016-05-09 | $3.10M derived: sum of 3 quarters · filed 2016-11-03 | $3.10M derived: sum of 4 quarters · filed 2016-11-03 |
| 2015-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $1.59M derived: sum of 2 quarters · filed 2016-11-03 | $1.59M derived: sum of 3 quarters · filed 2016-11-03 | $1.59M 10-K · filed 2016-03-08 |
| 2015-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.26M derived: sum of 2 quarters · filed 2016-11-03 | $1.26M 10-Q · filed 2016-11-03 | $1.26M derived: sum of 4 quarters · filed 2016-11-03 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | $0.00 derived: sum of 3 quarters · filed 2016-08-09 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | $0.00 derived: sum of 2 quarters · filed 2016-05-09 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $0.00 10-K · filed 2016-03-08 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |